Multiple endocrine neoplasia type 1 Clinical Trials
Conditions / Multiple endocrine neoplasia type 1
Delta Trials records 11 clinical trials for Multiple endocrine neoplasia type 1 in its publicly accessible dataset. From the full dataset, 5 actively seeking eligible participants and 2 trials have reached completion. This research is conducted across 30 study locations around the world. An additional 4 trials are active but not currently open for enrollment. Since 2020, 1 trial have been stopped, reflecting shifts in research priorities or feasibility. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
11
Total Trials
5
Recruiting
2
Completed
4
Other Active
1
Terminated since 2020
30
Study Locations
Browse by location (30 total)
- Houston, United States 4 trialsAll trials in Houston, United States
- Napoli, Italy 1 trialAll trials in Napoli, Italy
- Sesto Fiorentino, Italy 1 trialAll trials in Sesto Fiorentino, Italy
- Tampa, United States 1 trialAll trials in Tampa, United States
- Ferrara, Italy 1 trialAll trials in Ferrara, Italy
- Torino, Italy 1 trialAll trials in Torino, Italy
- Boston, United States 1 trialAll trials in Boston, United States
- Utrecht, Netherlands 1 trialAll trials in Utrecht, Netherlands
- Memphis, United States 1 trialAll trials in Memphis, United States
- Padua, Italy 1 trialAll trials in Padua, Italy
- Pisa, Italy 1 trialAll trials in Pisa, Italy
- Cagliari, Italy 1 trialAll trials in Cagliari, Italy
- Mexico City, Mexico 1 trialAll trials in Mexico City, Mexico
- Sioux Falls, United States 1 trialAll trials in Sioux Falls, United States
- Bari, Italy 1 trialAll trials in Bari, Italy
- Messina, Italy 1 trialAll trials in Messina, Italy
- Cuneo, Italy 1 trialAll trials in Cuneo, Italy
- Udine, Italy 1 trialAll trials in Udine, Italy
- Genova, Italy 1 trialAll trials in Genova, Italy
- Bethesda, United States 1 trialAll trials in Bethesda, United States